Clinical Trials Browser

Metastatic Castration-resistant Prostate Cancer × abiraterone × 1 year × Clear all

NCT07553988 2026-04-28

A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer